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SUMMARIES
ORIGINAL RESEARCH REPORTS
HEMATOPOIETIC STEM CELL TRANSPLANT 
OUTCOMES
Higher infused CD34+ cell dose and overall survival 
in patients undergoing in vivo T-cell depleted, but 
not t-cell repleted, allogeneic peripheral blood 
hematopoietic cell transplantation
In a retrospective analysis of 149 patients treated over a 7-year 
period, Kanate  and colleagues found that higher infused CD34+ 
cell dose improved overall survival, progression-free survival and 
nonrelapse mortality in the T-cell depleted group.
ADVERSE DRUG EFFECTS
Preliminary experience with the use of 
bendamustine: a peculiar skin rash as the 
commonest side effect
In this report from the Indian subcontinent, Malipatil and col-
leagues note that 9 of 16 patients developed a characteristic 
erythematous, papular skin rash that resolved after completion 
of chemotherapy with bendamustine. The drug is safe and a use-
ful addition against lymphoproliferative disorders, but a peculiar 
skin rash is a common side effect.
CANCER EPIDEMIOLOGY
A population-based study of the epidemiology 
and clinical features of adults with acute myeloid 
leukemia in Algeria: report on behalf of the 
Algerian Acute Leukemia Study Group
In a retrospective analysis of nationwide survey of all adult cases of 
AML, the annual incidence was 0.91/100 000 persons with a male 
to female (M/F) ratio of 1:16 and a median age of 45 years (range, 
16-82 years). The relatively younger age of patients compared to the 
Western countries may be due to the demographic composition of 
the population of Algeria.
POST-TRANSPLANT OUTCOMES
An approach to finding indications and 
contraindications for nephrectomy in post-
transplant renal graft lymphomas: PTLD.Int Survey
In a search of  reports of different treatment strategies addressing 
PTLD occurring within the allograft after renal transplantation, 
Gholipour-Shoiili and colleagues found that patients with renal 
allograft involvement who underwent allograft nephrectomy had 
a significantly better outcome compared to non-surgical patients, 
but patients with disseminated PTLD did not benefit from ne-
phrectomy.
CASE REPORTS
Durable complete response induced by paclitaxel-
nimotuzumab-methotrexate chemotherapy in a 
patient with metastatic head and neck squamous 
cell carcinoma
This third-line chemotherapy combination seems to be active 
but needs further evaluation in clinical trials to validate its use 
in heavily treated patients. The response was complete and main-
tained at 16 months in a 61-year-old male patient with metastatic 
poorly differentiated squamous cell carcinoma of the larynx to 
lymph nodes and lung.
Eight primary malignancies: case report and review 
of literature
The incidence of multiple primary malignancies has increased 
secondary to the long-term survival of cancer patients due to 
improvements in the early detection and adequate treatment of 
cancer. The authors recommend aggressive treatment, which suc-
ceeded in a 59-year-old female with Crohn disease with an other-
wise non-contributory medical history. 
Primary anaplastic large cell lymphoma of trachea 
with subcutaneous emphysema and progressive 
dyspnea
A 16-year-old female with an anaplastic large cell lymphoma 
with life-threatening airway obstruction and subcutaneous em-
physema had no evidence of local or distant recurrence after 25 
months following debulking and chemotherapy followed by local 
radiotherapy. This condition has a good prognosis if diagnosed 
immediately.
